Zilia Company
Zilia has developed a non-invasive platform technology that uses imaging, spectrometry and artificial intelligence to quantitatively measure different biomarkers in the human eye. Zilia’s initial product, Zilia Ocular, is the first retinal camera to quantify oxygen saturation, a crucial biomarker in ocular diseases such as glaucoma, DR and AMD. Zilia aims to revolutionize the prevention, diagnosis and management of these diseases by generating actionable data about the eye’s metabolic activity.
Founded Date:
2012-04-01
Last Funding Date:
2025-05-07
Industry:
Gyroscopy
Total Funding:
3198030
Headquarters:
Quebec,Quebec,Canada,North America
Employee Number:
11-50
Funding Status:
private
Super Industry:
Quantum Sensing
Funding Stage:
Seed
Funding Total Value:
4000000
Founders:
Dominic Sauvageau,Patrick Sauvageau
Phone Number:
1-833-501-6996